GRCh38/hg38 2q13(chr2:110104900-110201550)x1 AND See cases

Germline classification:
Conflicting classifications of pathogenicity (2 submissions)
Last evaluated:
Oct 20, 2010
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000135460.9

Allele description [Variation Report for GRCh38/hg38 2q13(chr2:110104900-110201550)x1]

GRCh38/hg38 2q13(chr2:110104900-110201550)x1

Genes:
LOC126806305:BRD4-independent group 4 enhancer GRCh37_chr2:110863055-110864254 [Gene]
LOC126806306:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:110906815-110908014 [Gene]
MALL:mal, T cell differentiation protein like [Gene - OMIM - HGNC]
NPHP1:nephrocystin 1 [Gene - OMIM - HGNC]
Variant type:
copy number loss
Cytogenetic location:
2q13
Genomic location:
Preferred name:
GRCh38/hg38 2q13(chr2:110104900-110201550)x1
HGVS:
  • NC_000002.12:g.(?_110104900)_(110201550_?)del
  • NC_000002.10:g.(?_110219766)_(110316416_?)del
  • NC_000002.11:g.(?_110862477)_(110959127_?)del
Links:
dbVar: nssv581929; dbVar: nssv582398; dbVar: nsv529129
Observations:
2

Condition(s)

Name:
See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000175180ISCA site 8

See additional submitters

no assertion criteria provided
Benign
(Oct 20, 2010) 		unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000175181ISCA site 17

See additional submitters

no assertion criteria provided
Uncertain significance
(Jul 30, 2009) 		unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providednot providedyes2not providednot providednot providednot providedclinical testing

Citations

PubMed

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, et al.

Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Review.

PubMed [citation]
PMID:
20466091
PMCID:
PMC2869000

Details of each submission

From ISCA site 8, SCV000175180.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providedDiscovery1not providednot providednot provided

From ISCA site 17, SCV000175181.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providedDiscovery1not providednot providednot provided

Last Updated: Apr 7, 2025

Modify your search Search (all fields optional) Clear all
Advanced Search